Fitzgerald D - Search Results

1

Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis.

Robinson PD, Cooper P, Van Asperen P, Fitzgerald D, Selvadurai H. Robinson PD, et al. Among authors: fitzgerald d. Pediatr Pulmonol. 2009 Aug;44(8):733-42. doi: 10.1002/ppul.20956. Pediatr Pulmonol. 2009. PMID: 19598271

2

Delayed diagnosis of cystic fibrosis in children with a rare genotype (delta F508/R117H).

Fitzgerald D, Van Asperen P, Henry R, Waters D, Freelander M, Wilson M, Wilcken B, Gaskin K. Fitzgerald D, et al. J Paediatr Child Health. 1995 Jun;31(3):168-71. doi: 10.1111/j.1440-1754.1995.tb00778.x. J Paediatr Child Health. 1995. PMID: 7669372 Review.

3

Diaphragmatic pacemaker failure in congenital central hypoventilation syndrome: a tale of two twiddlers.

Fitzgerald D, Davis GM, Gottesman R, Fecteau A, Guttman F. Fitzgerald D, et al. Pediatr Pulmonol. 1996 Nov;22(5):319-21. doi: 10.1002/(SICI)1099-0496(199611)22:5<319::AID-PPUL5>3.0.CO;2-F. Pediatr Pulmonol. 1996. PMID: 8931085

4

Dexamethasone for pulmonary interstitial emphysema in preterm infants.

Fitzgerald D, Willis D, Usher R, Outerbridge E, Davis GM. Fitzgerald D, et al. Biol Neonate. 1998;73(1):34-9. doi: 10.1159/000013957. Biol Neonate. 1998. PMID: 9458940

5

Higher SaO2 in chronic neonatal lung disease: does it improve sleep?

Fitzgerald D, Van Asperen P, Leslie G, Arnold J, Sullivan C. Fitzgerald D, et al. Pediatr Pulmonol. 1998 Oct;26(4):235-40. doi: 10.1002/(sici)1099-0496(199810)26:4<235::aid-ppul1>3.0.co;2-3. Pediatr Pulmonol. 1998. PMID: 9811072 Clinical Trial.

6

Sleep, respiratory rate, and growth hormone in chronic neonatal lung disease.

Fitzgerald D, Van Asperen P, O'Leary P, Feddema P, Leslie G, Arnold J, Sullivan C. Fitzgerald D, et al. Pediatr Pulmonol. 1998 Oct;26(4):241-9. doi: 10.1002/(sici)1099-0496(199810)26:4<241::aid-ppul2>3.0.co;2-1. Pediatr Pulmonol. 1998. PMID: 9811073

7

Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients.

Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Wood LG, et al. Am J Clin Nutr. 2002 Apr;75(4):668-75. doi: 10.1093/ajcn/75.4.668. Am J Clin Nutr. 2002. PMID: 11916752 Clinical Trial.

8

Non-compliance in adolescents with chronic lung disease: causative factors and practical approach.

Fitzgerald D. Fitzgerald D. Paediatr Respir Rev. 2001 Sep;2(3):260-7. doi: 10.1053/prrv.2001.0149. Paediatr Respir Rev. 2001. PMID: 12052328 Review.

9

Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function.

Wood LG, Fitzgerald DA, Lee AK, Garg ML. Wood LG, et al. Am J Clin Nutr. 2003 Jan;77(1):150-9. doi: 10.1093/ajcn/77.1.150. Am J Clin Nutr. 2003. PMID: 12499335 Clinical Trial.

10

Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis.

Skowronski E, Fitzgerald DA. Skowronski E, et al. Med J Aust. 2005 May 2;182(9):482-3. doi: 10.5694/j.1326-5377.2005.tb06792.x. Med J Aust. 2005. PMID: 15865595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results